Lentiviral Minigene Vaccine
Lentiviral Minigene Vaccine Uses, Dosage, Side Effects, Food Interaction and all others data.
LV-SMENP-DC is a vaccine candidate being developed by Shenzhen Geno-Immune Medical Institute that comprises dendritic cells that are modified with lentiviral vector-expressing synthetic minigene which are based on domains of selected viral proteins. This vaccine is also administered with antigen-specific cytotoxic T lymphocytes (CTLs).
As of August 2020, this vaccine is being tested for prophylaxis against COVID-19 in human clinical trials.
Trade Name | Lentiviral Minigene Vaccine |
Generic | LV-SMENP Vaccine |
LV-SMENP Vaccine Other Names | Covid-19 Synthetic Minigene Vaccine, Lentiviral Minigene Vaccine, LV-SMENP |
Type | |
Groups | Investigational |
Therapeutic Class | |
Manufacturer | |
Available Country | |
Last Updated: | September 19, 2023 at 7:00 am |
Innovators Monograph
You find simplified version here Lentiviral Minigene Vaccine